(Press-News.org) Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all standard therapies.
About one-third of aplastic anemia cases do not respond to standard therapy, a combination of immune-suppressing drugs. Although bone marrow stem cell transplantation is an option for some, patients without a matched donor have few treatment options. The findings of this new clinical study, carried out by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, suggest eltrombopag could be a second-line therapeutic option for them.
"Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia," will be published online July 5 in the New England Journal of Medicine.
Aplastic anemia is a rare blood disorder, with about 600 new cases in the U.S. each year. Aplastic anemia results from the destruction of bone marrow stem cells, which mature into red blood cells that carry oxygen, white blood cells that fight infection, and platelets that prevent excess bleeding. Symptoms of the disorder include fatigue, frequent infections, and hemorrhaging. In severe cases unresponsive to treatment, death can occur.
Eleven of 25 participants enrolled in this phase 2 study showed improved production of at least one type of blood cell (red blood cell, white blood cell, or platelet) after 12 weeks of oral eltrombopag therapy. Among the seven volunteers who continued taking the pills long-term (8-32 months), six eventually showed an improvement in all three types of blood cells, and were able to maintain safe blood counts without needing red blood cell or platelet transfusions. Overall the drug was well tolerated, with few side effects.
The research team in the NHLBI Hematology Branch tested eltrombopag because this drug had previously been shown to boost platelet levels in both healthy people and people with reduced platelets due to hepatitis C infection or immune thrombocytopenia, blood disorders that like aplastic anemia result in low platelet counts and increased risk of bleeding.
The encouraging finding in this study was improvement in red blood cell and white blood cell counts in some aplastic anemia patients, suggesting that the drug can stimulate bone marrow stem cells and perhaps have wider utility than initially predicted.
INFORMATION:
Learn more about this study at: http://clinicaltrials.gov/ct2/show/NCT00922883
Learn more about aplastic anemia at: http://www.nhlbi.nih.gov/health/health-topics/topics/aplastic/
Cynthia Dunbar, M.D., senior investigator in the NHLBI's Hematology Branch and a coauthor on the study, is available to comment on the study's findings and implications for future clinical studies with eltrombopag.
For Dr. Dunbar's complete bio, please visit: http://www.nhlbi.nih.gov/news/spokespeople/dunbar-cynthia.html
For more information or to schedule an interview, contact the NHLBI Communications Office at 301-496-4236 or nhlbi_news@nhlbi.nih.gov.
END
Scientists at the University of East Anglia (UEA) have discovered a 'constant cloud' of potent inflammatory molecules surrounding the cells responsible for diseases such as thickening of the arteries and rheumatoid arthritis.
Published online today by The Journal of Cell Science, the findings could eventually lead to new treatments for chronic inflammatory diseases. Cardiovascular disease arising from atherosclerosis (thickening of the arteries) kills around 17 million people worldwide each year, including 120,000 people in England and Wales, while rheumatoid arthritis ...
Data Papers are a new type of scholarly articles, which are rapidly gaining momentum in the scientific community. They are peer-reviewed scholarly publications that describe data sets and provide an opportunity for data authors to receive the academic credit through citation and re-use of the published data. Data Papers of this kind have been recently published in cooperation among the international organization Global Biodiversity Information Facilities (GBIF) and the journals ZooKeys and PhytoKeys.
Most online keys to identify biodiversity (e.g., species and genera) ...
Insufficient progress has been made in most developing countries to meet the United Nations' target of halving the proportion of children who suffer from hunger by 2015 compared with 1990 levels, according to a systematic analysis of data on children's height and weight, published today in the Lancet. Although the nutritional status of children under five has improved overall since 1985, one in five infants and children in developing countries is still moderately or severely underweight, amounting to an estimated 110 million children worldwide. Another 148 million are mildly ...
Seabirds feed their young less as they reach an age to fly the nest, but it's hormones that actually control when the chicks leave home, according to new research from the University of Leeds.
The study – published online in Behavioural Ecology today (05 July) – aimed to pinpoint the main trigger which causes chicks to leave the nest and embark on an independent life, a process known as fledging.
While studying a colony of Manx Shearwaters (Puffinus puffinus), on the island of Skomer, researchers from the University's Faculty of Biological Sciences noticed that parent ...
Cambridge and Boston, MA. Wed. July 4, 2012 – One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?
New research by a team from the Broad Institute, Dana-Farber Cancer Institute, and Massachusetts General Hospital suggests ...
Tendon disorders cost the UK economy more than £7bn a year and now scientists at Queen Mary, University of London have identified a vital component of tendons which could help treat them.
The research, published in the highly regarded Royal Society journal Interface today (4 July), found that a component of tendons known as the interfascicular matrix (IFM) is essential for their function.
"Tendon disorders are highly debilitating and painful, and may herald the end of an Olympic athlete's career," said co-author Dr Hazel Screen, a senior lecturer in medical engineering ...
(TORONTO, July 4, 2012) – A team of international scientists led by principal investigator Dr. Tak Mak at the Princess Margaret Cancer Centre, University Health Network, has identified a causative link between the product of a mutated metabolic enzyme and the onset of acute myeloid leukemia (AML), one of the most common types of leukemia in adults.
Called an "oncometabolite" for its role in cancer metabolism, the metabolite2-hydroxyglutarate (2HG) is a by-product of a gene mutation of an enzyme known as isocitrate dehydrogenase (IDH).
Says Dr. Tak Mak of the findings ...
Researchers have taken a step toward personalized medicine for Parkinson's disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments. The study was funded by the National Institutes of Health.
The researchers collected skin cells from patients with genetically inherited forms of Parkinson's and reprogrammed those cells into neurons. They found that neurons derived from individuals with distinct types of Parkinson's showed common signs of distress and vulnerability – in particular, abnormalities in the ...
Fotoclipping.com, a complete graphic design solution provider is now offering seasonal offers for image on Image Manipulation service together with Clipping path, Image masking, model photo retouch, Color correction, Photo Re-shaping, HDR Photoshop effect, Pop Art Creation, Typography, Panoramic Photography 360 & Photo Album services with guaranteed top most quality service and fast turnaround time.
Fotoclipping.com has earned global market experience as outsourcing graphics design service provider. We have already reached our excellent graphics design and image ...
MobiPixie team today announced the official launch of its MobiPixie platform and mobile applications. Mobipixie is an advanced photo media sharing & social networking platform for mobile phone users. Mobipixie provides a unique platform for sharing life's memories captured as photos with people that a user loves & cares, with full privacy control. The application is currently available on Android. iPhone, Blackberry and J2ME applications are to be released shortly.
The Mobipixie platform can be accessed at http://www.mobipixie.com. The MobiPixie Android application ...
